# OnCo record qt-prolongation (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/qt-prolongation/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "qt-prolongation" ;
  schema:name "QT prolongation"@en ;
  schema:alternateName "QTc prolongation"@en, "QTc"@en, "QT interval"@en, "prolonged QT"@en, "QT"@en, "ECG monitoring"@en, "electrocardiogram"@en, "hERG"@en, "hERG inhibition"@en, "torsades"@en, "torsades de pointes"@en, "ventricular arrhythmia"@en, "electrolyte monitoring"@en ;
  schema:description "A change on the heart's electrical trace, caused by some drugs blocking a potassium channel (hERG), that in rare cases sets off a dangerous rhythm. Drugs that do this need ECG checks and care with other medicines and low potassium or magnesium."@en ;
  schema:url <https://onco.cc/terms/qt-prolongation/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Long_QT_syndrome#Drug-induced> ;
  schema:citation <https://en.wikipedia.org/wiki/Long_QT_syndrome#Drug-induced> ;
  onco:related <https://onco.cc/terms/cardiotoxicity/>, <https://onco.cc/terms/therapeutic-index/>, <https://onco.cc/terms/tki-term/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:drugs <https://onco.cc/drugs/nilotinib/>, <https://onco.cc/drugs/ribociclib/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/arsenic-trioxide/> .